Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical issues in growth hormone therapy.

J Lantos1, M Siegler, L Cuttler

  • 1Department of Pediatrics, University of Chicago, Pritzker School of Medicine, IL 60637.

JAMA
|February 17, 1989
PubMed
Summary

Growth hormone (GH) therapy for short children without GH deficiency presents ethical challenges. Such treatment should be part of clinical research, not routine care, due to uncertain benefits and risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Europa's ice thickness and subsurface structure characterized by the Juno microwave radiometer.

Nature astronomy·2026
Same author

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Clinical pharmacology and therapeutics·2017
Same author

Prognostic neurodevelopmental testing of preterm infants: do we need to change the paradigm?

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.

Clinical pharmacology and therapeutics·2016
Same author

l-Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same author

Equipoise: ethical, scientific, and clinical trial design considerations for compatible pair participation in kidney exchange programs.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Area of Science:

  • Pediatric Endocrinology
  • Medical Ethics
  • Child Health Policy

Background:

  • Pediatricians grapple with ethical dilemmas regarding growth hormone (GH) therapy for short children lacking classic GH deficiency criteria.
  • Biological health norms are insufficient for evaluating GH therapy due to the complex relationship between stature, GH secretion, health, and disease.

Purpose of the Study:

  • To evaluate the ethical considerations of GH therapy for short children without documented GH deficiency.
  • To compare GH therapy for short normal children with accepted treatments for other non-life-threatening pediatric conditions.

Main Methods:

  • Analysis of clinical and ethical dilemmas surrounding GH therapy.
  • Comparison of GH therapy with established pediatric care models (well-child care, cosmetic therapy, psychological treatment, chronic condition management).
Keywords:
Analytical ApproachProfessional Patient Relationship

Related Experiment Videos

Main Results:

  • GH therapy for short children without documented deficiency poses ethical concerns due to treatment burdens, uncertain long-term outcomes, and unclear endpoints.
  • Current pediatric ethical norms do not support routine GH therapy for these children.

Conclusions:

  • Routine GH therapy for short children without documented GH deficiency falls outside current pediatric ethical standards.
  • Such therapy should be administered within comprehensive clinical research protocols to address ethical and safety concerns.